Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial ...

Eyes On Litchfield Announces Expanded Clinical Services And Community Screenings. <a href = target=_blank><br/><img src=' ...

Through 24 months, scleral bio-reinforced cyclodialysis combined with cataract surgery lowered IOP by enhancing uveoscleral outflow, according to a study published in Ophthalmology Science. "The ...

Advancing Sight Network and Miracles In Sight today jointly announced the merger of the two organizations, which will begin operating as one on January 1, 2026.

Specialists discuss diagnostic technologies, treatment strategies, and research that are improving outcomes for young ...

Expect to pay at least $1,500 per eye depending on the pro­cedure and the equipment. If you haven't bought a new pair of ...

Presenters at the AAO 2025 meeting outlined a future for retinal care that reduces patient burden by reconsidering treatment delivery methods.

Motorists are being alerted to an important date that’s fast-approaching. On social media, the DVLA Personalised Registration ...

Alongside a picture of the plate, it mentioned there is a time limit for anyone interested in it. It added: "It's available ...

In 2020, the International Agency for the Prevention of Blindness' "Vision Atlas" estimated about three million Sudanese suffered from visual impairment ... Hajo stressed that early detection and ...